The value of genetic polymorphisms to predict toxicity in metastatic colorectal patients with irinotecan-based regimens
![Thumbnail](/xmlui/themes/Mirage2//images/thumbnails/thumn_cientif.png)
Identificadores![](/xmlui/themes/Mirage2//images/despl_identif.png)
Identificadores
Fecha de publicación
2012Título de revista
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Tipo de contenido
Artigo
![](/xmlui/themes/Mirage2//images/final_lines.png)